The restructuring by Novartis resulting in the loss of 320 jobs by mid-2022 has been met with disappointment by Cork Chamber.
Commenting, Conor Healy, Cork Chamber CEO, said:
“Novartis has been a major employer in Ringaskiddy for over 25 years and is a significant player in the pharma and life sciences sectors that Cork is globally recognised for.
“Our immediate thoughts are with the impacted employees and their families at this stressful time and we encourage the State agencies to work with the company and the employees to ensure that all available reemployment opportunities are identified.”
“The pharma and medtech industries employ over 15,000 people in Cork and both sectors have seen growth of over 50% since 2010. Cork Chamber will continue to work to support the growth of this key sector in Cork and drive new opportunities in the region for the highly skilled 320 people affected by this decision.”